feed,title,long_url,short_url
Benzinga,BELLUS Health Announces FDA End-of-Phase 2 Meeting For Refractory Chronic Cough Program,https://benzinga.com/general/biotech/22/07/28030979/bellus-health-announces-fda-end-of-phase-2-meeting-for-refractory-chronic-cough-program,https://bit.ly/3RvWQ5Z
